Importantly, combination therapy with CSF-1 and anti–P selectin blocks monocyte transmigration into tissues, further bolstering PMo numbers and conferring better protection against stasis in SCD mice than either treatment alone. Here, CSF1 is linked to Schnyder corneal dystrophy.